Jim Cramer Says Intel (INTC) Situation is ‘Fraught’
We recently published a list of 10 Jim Cramer Stocks to Watch in 2025. In this article, we are going to take a look at where ...
Jim Cramer opines on TikTok ban: 'Let's just call it anybody’s ballgame'
CNBC's Jim Cramer on Wednesday gave investors his read on the future of TikTok, saying the popular app faces a contentious battle even up against a conservative-leaning Supreme Court. A law passed ...
Jim Cramer urges investors to sell volatile stocks in quantum computing: 'I can't be part of this froth'
CNBC's Jim Cramer on Wednesday told investors to be wary of market froth, especially volatile stocks related to quantum computing.
Jim Cramer looks ahead to Friday's employment data: ‘We're at the mercy of macro numbers'
Reviewing Tuesday's market-wide decline, CNBC's Jim Cramer attributed much of the pullback to investors' worries about ...
Has Jim Cramer Lost Faith in Biogen Inc. (BIIB)’s Struggles with Alzheimer’s and MS Challenges?
We recently published a list of Jim Cramer Discussed These 10 NASDAQ 100 Stocks Recently. In this article, we are going to ...
Jim Cramer says Nvidia's pullback could be a good chance to buy
CNBC’s Jim Cramer extolled Nvidia’s stock and reviewed its Tuesday action, saying the decline was unrelated to the company ...
Jim Cramer's four big-picture questions for 2025
CNBC’s Jim Cramer on Friday opined on the uncertainty of 2025 and listed four of the most pressing macroeconomic questions he ...
Jim Cramer Predicts Palantir Buying Surge Tonight After Morgan Stanley's Underweight Rating: 'Unless Another Analyst Starts With A Sell...'
Morgan Stanley initiated coverage of Palantir Technologies Inc. (NYSE:PLTR) with an underweight rating and $60 price target ...
Jim Cramer Sees Buying Opportunity In Nvidia But Attributes 6% Fall To 'Too Much Hot Money' After Jensen Huang's CES Keynote
Jim Cramer urged investors to consider NVIDIA Corp.'s recent stock decline as a buying opportunity, despite the company's ...
Jim Cramer explores why consumer goods stocks are seeing losses
CNBC’s Jim Cramer reviewed Monday’s market action and gave his take on why a large swath of stocks are notching losses.
Jim Cramer: Lemonade Is 'Up Too Much,' This Health Care Stock Can Go Lower
JMP Securities analyst Ronald Josey maintained Lemonade with a Market Outperform and raised the price target from $40 to $60.
Jim Cramer cautions against speculating on nuclear power and quantum computing
CNBC’s Jim Cramer on Thursday warned investors about speculating too heavily in sectors such as nuclear power and quantum ...